Instruction for use: Eyfitol

Dosage form: caps, Oral solution

Pharmacological groups

Antiaggregants

Other lipid-lowering drugs

Supplements - fats, fat-like substances and their derivatives

Supplements - polyphenolic compounds

The nosological classification (ICD-10)

D84.9 Unspecified Immunodeficiency: Pneumonia in immunodeficient states; Autoimmune disease; Autoimmune diseases; Severe immunodeficiency; immune deficiency; Immunodeficiency; immunodeficiency diseases; Immunodeficiency states due to surgery; Immunotherapy for cancer; Immunomodulation; Infections in patients with weakened immune systems; Correction of immune deficiency; Correction of immunodeficiencies; Correction of a weakened immune system; Correction of a weakened immunity in immunodeficient states; Violation of immunity; Violation of the immune status; Immune System Disorders; Primary immunodeficiency; Maintaining immunity; Lowering the body's defenses; Lowering the immunity; Lowering the immunity of colds and infectious diseases; The decrease of the immune status; Lowered resistance to infections; Lowered resistance to infections and colds; Lowered resistance; Immunosuppression; Predisposition to colds; acquired immune deficiencies; Radiation immunodeficiency; The development of immunodeficiency; Immune dysfunction syndrome; immunodeficiency syndrome; primary immunodeficiency syndrome; Reducing the body's defenses; Immunosuppression; Reduced immune defense; Reducing local immunity; Reducing the total body resistance; The decrease in cell-mediated immunity; Reduced resistance to infections in children; Reducing the body's resistance; Reduced resistance; reduced immunity; Status immunodeficiency; Stimulation of the processes of nonspecific immunity; Heavy selective secondary immunodeficiency; immunity Oppression; Primary immunodeficiency

E78.5 Unspecified Hyperlipidemia: associated hypercholesterolemia; Secondary hyperlipoproteinemia; Hyperlipidemia; Hyperlipidemia Type II; Hyperlipidemia IIa; hyperlipoproteinemia; Hyperlipoproteinemia type IIa; Type IIb hyperlipoproteinemia; The combined hypercholesterolemia and hypertriglyceridemia; Correction of lipid metabolism disorders; The increased value of LDL

F52.2 Lack of genital response: Secondary impotence; hyposexuality; Impotence; Impotence on the basis of neurasthenia; Impotence against the background of functional nervous disorders; Impotence of different origin; Violation potency; erectile Dysfunction; potency Disorders; erectile dysfunction; Erectile dysfunction of various origins; Lack of erection; The weakening of potency; The weakening of sexual activity; The weakening of erection; Lowering the male potency; Sexual disorders in men; Sexual dysfunction; Weak potency; Reduced potency; Reduced potency; erectile disfunction; Erectile dysfunction, neurogenic

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I21 Acute myocardial infarction: Myocardial infarction in the acute phase; Acute Myocardial Infarction; Myocardial infarction with pathologic Q wave and without; Myocardial infarction complicated by cardiogenic shock; Infarction left ventricular; Transmural myocardial infarction; Myocardial infarction netransmuralny (subendocardial); Netransmuralny myocardial infarction; Subendocardial myocardial infarction; The acute phase of myocardial infarction; Acute myocardial infarction;Sub-acute phase of myocardial infarction; Subacute phase of myocardial infarction; Thrombosis of the coronary arteries (the arteries); Threatened myocardial infarction; Myocardial infarction without Q wave

I25 Chronic ischemic heart disease: Coronary heart disease on the background of hypercholesterolemia; Coronary heart disease is a chronic; Coronary heart disease; Stable coronary artery disease; Percutaneous transluminal angioplasty; Myocardial ischemia, arteriosclerosis; Recurrent myocardial ischemia

I25.1 Atherosclerotic heart disease: Atherosclerosis and the likelihood of reinfarction; Atherosclerosis of the coronary vessels; Atherosclerotic heart disease; Atherosclerotic cardio; The coronary atherosclerosis; cardiosclerosis; cardiosclerosis atherosclerotic; Coronary atherosclerosis; Coronary atherosclerosis in patients with coronary artery disease; koronaroskleroza; Myocardial ischemia, arteriosclerosis

I64 Unspecified Stroke as a bleeding or heart attack: Primary stroke; Stroke; Stroke in the course of; microstroke; stroke; The completed stroke

I67.2 Cerebral atherosclerosis: Atherosclerosis of the arteries of the brain; Atherosclerosis of cerebral vessels; Atherosclerotic changes in cerebral vessels; Vascular diseases of the brain; Sclerotic ischemic attacks; Sclerosis of cerebral vessels

I70 Atherosclerosis: Atherosclerosis; Atherosclerosis of peripheral vessels; Atherosclerotic changes; Atherosclerotic vascular changes; Atherosclerotic disorders; spontaneous; Trombangioz obliterans; Frinlendera disease

J06 Acute upper respiratory infections of multiple and unspecified location: Frequent colds viral diseases; Infections of the upper respiratory tract; Acute respiratory disease influenza character; for colds Pain; Acute colds; Colds; respiratory infection; Seasonal colds; Pain in infectious and inflammatory diseases of the upper respiratory tract; Bacterial infections of the upper respiratory tract; Bacterial respiratory infections; Viral disease of the respiratory tract; Viral respiratory tract infections; Inflammatory disease of the upper respiratory tract; Inflammation of the upper respiratory tract disease; Inflammation of the upper respiratory tract illness with difficult sputum; Inflammatory airway disease; Secondary infections with colds; Shortness of sputum in acute and chronic respiratory diseases; Upper respiratory tract infection; Infections of the upper respiratory tract; Respiratory Tract Infections; Infections of the respiratory tract and lungs; Infectious-inflammatory diseases of the upper respiratory tract and ENT-organs; Infectious-inflammatory diseases of the upper respiratory tract in children and adults; Infectious-inflammatory diseases of the upper respiratory tract; Infectious inflammation of the airways; respiratory infection; Qatar upper respiratory tract; Catarrh of the upper respiratory tract; Catarrhal symptoms of the upper respiratory tract; Cough in diseases of the upper respiratory tract; Coughing with a cold; SARS; ARI; ARI with rhinitis phenomena; Acute respiratory infection; Acute infectious and inflammatory disease of the upper respiratory tract; Acute respiratory disease; Sore throat or nose; Respiratory viral infections; Respiratory diseases; Respiratory infections; Recurrent respiratory infections; Secondary infection with influenza; cold in the chest; Feverish condition with flu

J11 Influenza, virus not identified: Influenza; Influenza in the early stages of the disease; Influenza in children; cold in the chest; Begins flu-like condition; Acute disease parainfluenza; parainfluenza; parainfluenza state; influenza epidemics; The pains of the influenza

Z100 * CLASS XXII Surgical practice: Abdominal surgery; adenomectomy; Amputation; Coronary angioplasty; Angioplasty of the carotid arteries; Antiseptic skin treatment for wounds; Antiseptic Hand; Appendectomy; atherectomy; Balloon coronary angioplasty; Vaginal hysterectomy; The coronary bypass; Interventions in the vagina and cervix; Interventions on the bladder; Intervention in the mouth; Restoration and reconstructive surgery; Hand hygiene of medical personnel; Gynecologic surgery; Gynecological intervention; Gynecological surgery; Hypovolemic shock during operations; Disinfection of purulent wounds; Disinfection of wounds edges; Diagnostic intervention; Diagnostic procedures; Cervical Diathermocoagulation; Long-surgery; Replacing the fistula catheters; Infection in orthopedic surgery; Artificial heart valve; cystectomy; Short-term outpatient surgery; Short-term operation; Short surgical procedures; Krikotireotomiya; Blood loss during surgery; Bleeding during surgery and in the postoperative period; Kuldotsentez; laser photocoagulation; laser coagulation; retinal laser coagulation; Laparoscopy; Laparoscopy in Gynecology; CSF fistula; Small gynecological operations; Small surgical procedures; Mastectomy and subsequent plastic; mediastinotomy; Microsurgical operations on the ear; Mukogingivalnye operation; suturing; Minor surgery; neurosurgical operation; Immobilization of the eyeball in ophthalmic surgery; testectomy; pancreatectomy; Perikardektomiya; The period of rehabilitation after surgery; The period of convalescence after surgery; Percutaneous transluminal coronary angioplasty; Pleural thoracentesis; Pneumonia postoperative and posttraumatic; Preparation for surgical procedures; Preparation for surgery; Preparation of the surgeon's hands before surgery; Preparation of the colon for surgical procedures; Postoperative aspiration pneumonia in neurosurgical and thoracic surgery; Postoperative nausea; Postoperative bleeding; postoperative granuloma; postoperative shock; The early postoperative period; myocardial revascularization; Radiectomy; gastric Resection; bowel resection; uterine Resection; liver Resection; enterectomy; Resection of part of the stomach; Reocclusion of the operated vessel; Bonding tissues during surgical procedures; Removal of sutures; Condition after eye surgery; Condition after surgery; Condition after surgery in the nasal cavity; Condition after gastrectomy; Status after resection of the small intestine; Condition after tonsillectomy; Condition after removal of the duodenum; Condition after phlebectomy; Vascular surgery; Splenectomy; Sterilization of surgical instruments; Sterilization of surgical instruments; sternotomy; Dental surgery; Dental intervention in periodontal tissues; strumectomy; Tonsillectomy; Thoracic surgery; Thoracic surgery; total gastrectomy; Transdermal intravascular coronary angioplasty; Transurethral resection; Turbinektomiya; Removal of a tooth; cataract surgery; Removal of cysts; tonsillectomy; Removal of fibroids; Removing the mobile primary teeth; Removing polyps; Removing broken tooth; Removal of the uterus body; Removal of sutures; Fistula likvoroprovodyaschih ways; Frontoetmoidogaymorotomiya; Surgical infection; Surgical treatment of chronic limb ulcers; Surgery; The surgery in the anal area; The surgery on the colon; Surgical practice; The surgical procedure; Surgical interventions; Surgery on the gastrointestinal tract; Surgical procedures on the urinary tract; Surgical procedures on the urinary system; Surgical intervention of the genitourinary system; Surgical procedures on the heart; Surgical manipulation; surgery; Surgery on the veins; Surgical intervention; Vascular surgery; Surgical treatment of thrombosis; Surgery; cholecystectomy; Partial gastric resection; hysterectomy; Percutaneous transluminal coronary angioplasty; Percutaneous transluminal angioplasty; Coronary artery bypass; tooth Extirpation; Extirpation of milk teeth; pulpectomy; pulsative cardiopulmonary bypass; tooth Extraction; teeth Extraction; cataract extraction; Electrocoagulation; endourological intervention; episiotomy; Etmoidotomiya; Complications after tooth extraction

Z29.1 Prophylactic immunotherapy: Vaccination against viral infections; donor Vaccination; Vaccination and revaccination; Vaccination of newborns; Vaccination against hepatitis B; Immunization; Correction of the immune status; Therapeutic and prophylactic immunization; Preventive immunization; Specific immunoprophylaxis; Stimulation of the processes of nonspecific immunity

Z54 recovery period: The recovery period; The recovery period after illness; Recovery; The recovery from the flu and colds; Recovery after illness; The lack of mineral salts in the period of convalescence; The period of recovery after illness; The period of recovery after illness and surgery; The period of recovery after a serious illness; The period of convalescence after illness; rehabilitation period; rekovalestsentsii period after infectious diseases; decubation; The period of convalescence after surgery and infectious diseases; The period of convalescence after prolonged infections; The period of convalescence after serious diseases; The period of convalescence after severe infections; Rehabilitation period; convalescent state; Convalescence after illness; Convalescence after infectious diseases; Convalescence after debilitating diseases; Convalescence after infectious diseases; Convalescence at an elevated blood loss; Status of convalescence after illness

Structure and Composition

1 capsule contains a mass of 0.45 g of polyunsaturated fatty acids omega-3 family (eicosapentaenoic and docosahexaenoic) volatile and garlic; in banks 30, 70 and 100 pieces.

Characteristics

Dietary food supplement containing omega-3 fatty acids - at least 25%, E vitamins - not less than 0.45 mg A - 0.01 mg not less than, D - not less than 0.45 g, and volatile garlic. Obtained from the tissue of fish oil and garlic extract on original domestic technology (Patent RF N 2005390).

Pharmachologic effect

Mode of action - fibrinolytic, antiagregatine, hypotensive, hypocholesterolemic.

Normalizes LDL and VLDL structure that alters the properties of cell membranes and increases the functional activity of receptors has hypolipidemic activity reduces the content of arachidonic and increases - eicosapentaenoic acid in the membranes of platelets, inhibits the synthesis of thromboxane A2 and eicosanoid enhancing clot formation and increases the formation of thromboxane A3 and eicosanoids line E3, non-proagregatsionnym effect; enhances the transport of vasoactive substances and has anti-inflammatory effect (allicin).

Pharmacodynamics

Reduces cholesterol and triglycerides in the plasma for hyperlipidemia, atherosclerosis slows promotes resorption of existing plaque, reduces blood glucose level and blood pressure, inhibits platelet aggregation, normalizes hemocoagulation, promotes lysis of fresh clots.

Clinical pharmacology

Prolonged use in coronary artery disease reduces the frequency of angina attacks, the daily need for nitroglycerin, improves exercise tolerance.

Recommended

Atherosclerosis, dyslipidemia, coronary heart disease, hypertension, atherosclerosis of the lower limbs, impotence, decreased immunity; prevention of myocardial infarction and stroke, postoperative complications in patients with vascular disease, flu and colds, premature aging of the organism.

Contraindications

Hypersensitivity, human liver, gallstone disease, hemorrhagic syndrome.

Dosing and Administration

Inside, in the morning, 30 minutes after a meal, without chewing, drinking plenty of water.

Prevention: children 1 caps / day, adults - 4 caps / day...

Diseases of the cardiovascular system: in a daily dose of 3 capsules / 20 kg 1-2 reception.. Course - 3 months.

Prevention of aging: Day 1 - 3 capsules, Day 2 - 10 caps, 3 day - 15 caps, 4 th day - 21 caps, 5 - Day 6 - 25 caps., day 7 - 21 caps, 8 th day -. 13 caps, 9 th day - 9 caps, the 10th day - 5 caps, the 11th day - 4 caps. Receiving repeated every 11 days. Course - 6 months (treatment is carried out without interruption of 16 cycles of 11 days).

Storage conditions of the drug Eyfitol

In a cool, dry, dark place.

Keep out of the reach of children.

The shelf life of the drug Eyfitol

3 years.

Do not use beyond the expiration date printed on the package.